SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001140361-24-024020
Filing Date
2024-05-02
Accepted
2024-05-02 16:25:48
Documents
7
Period of Report
2024-06-17

Document Format Files

Seq Description Document Type Size
1 DEF 14A ny20024009x1_def14a.htm DEF 14A 1439176
2 ny20024009x1_graph01.jpg GRAPHIC 136844
3 ny20024009x1_pc01.jpg GRAPHIC 673992
4 ny20024009x1_pc02.jpg GRAPHIC 682717
5 ny20024009x1_piechart01.jpg GRAPHIC 94195
6 ny20024009x1_pvp01x2.jpg GRAPHIC 152190
7 ny20024009x1_pvp02x2.jpg GRAPHIC 123198
  Complete submission text file 0001140361-24-024020.txt   4004912
Mailing Address 100 CARDINAL WAY REDWOOD CITY CA 94063
Business Address 100 CARDINAL WAY REDWOOD CITY CA 94063 (650) 649-1004
Adverum Biotechnologies, Inc. (Filer) CIK: 0001501756 (see all company filings)

IRS No.: 205258327 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36579 | Film No.: 24908834
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)